Brief: Saladax Biomedical And Hls Therapeutics Strengthen Partnership With An Exclusive Distribution Agreement For Canada
18/11/2021 18:29
HLS Therapeutics Inc HLS.TO :
* SALADAX BIOMEDICAL AND HLS THERAPEUTICS STRENGTHEN
PARTNERSHIP
WITH AN EXCLUSIVE DISTRIBUTION AGREEMENT FOR CANADA
Source text for Eikon: ID:nBw6bVf7za
Further company coverage: HLS.TO
Recent news on HLS Therapeutics
See all newsBrief: Hls Therapeutics Increases Normal Course Issuer Bid
Brief: HLS Therapeutics Announces Q2 2026 Financial Results
Canada's HLS Therapeutics Q2 revenue rises on higher cardiovascular drugs demand
Brief: HLS Therapeutics - Secures Nilemdo Reimbursement With Private Payers Covering 80% Of Privately Insured Canadians
Canada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group